Overview

A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess how well the combination of pemetrexed with cisplatin can reduce tumor size.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Cisplatin
Dexamethasone
Folic Acid
Hydroxocobalamin
Pemetrexed
Vitamin B 12